SPORCK ALISTAIR N sold $108K of AEHR

SPORCK ALISTAIR N (VP Contactor Business Unit) sold 1,000 shares of AEHR TEST SYSTEMS (AEHR) at $108.49 ($0.11M total) on 2026-08-10.

Original reporting
SEC EDGAR · SPORCK ALISTAIR N
Published Aug 11, 2026, 6:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 6:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AEHR
Neutral
medium confidence
Mentioned
$AEHR
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AEHRNeutralLow
01

Why it matters

The newest fact is the specific open-market sale: 1,000 shares at $108.49 on 2026-08-10, with holdings after the sale of 22,547 shares.

02

Market read

Traders may note the insider sale for sentiment, but the transaction size and lack of company-specific news limit trading impact.

03

What to watch

Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs, so this should not be treated as a directional earnings signal without corroborating fundamentals.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-11, transaction dated 2026-08-10

Background

This is an SEC Form 4 insider transaction for AEHR Test Systems, reported by VP AlistaIr N Sporck.

Company-level read

Ticker impact

$AEHRNeutralMedium confidence
Context

AEHR insider Form 4 shows VP AlistaIr N Sporck sold 1,000 shares on 2026-08-10 at $108.49, worth about $108.5K.

Expected impact

Likely minimal near-term impact; any effect would be sentiment-only and typically fades quickly.

Evidence & confidence

The filing is a primary SEC Form 4 disclosure, but the transaction size is small relative to typical AEHR trading and lacks accompanying company-specific catalysts.

Market effects

No clear read-through to the medical device or test systems sector from a single small insider sale.

None indicated.

None indicated.

Counterpoint

The absence of a disclosed 10b5-1 plan could be interpreted as less systematic selling, but the disclosed value is still modest.

Key entities

  • AEHR Test Systems

    Company subject of the Form 4 insider transaction disclosure.

  • SPORCK ALISTAIR N

    VP, Contactor Business Unit, who executed the open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AEHRHighAI 9/10

Aehr Test Systems (AEHR) (Q1 2027) Earnings Call Highlights: Record Revenue, Raised

Aehr Test Systems (AEHR) reported record Q1 2027 revenue of $33M and raised annual guidance to $150M. CEO Gayn Erickson highlighted a potential large burn-in opportunity, estimating $35M-$70M in revenue per million units shipped. The company expects sequential growth in remaining quarters, with Q4 potentially the highest. Management confirmed they are not supply-constrained and can ship more than guided. Silicon carbide revenue was about $10M in fiscal 2026, with expectations for growth in 2027.

$AEHRHighAI 9/10

AEHR Stock Surges After Massive AI-Driven Earnings Beat

Aehr Test Systems (AEHR) stock rose 26.6% after reporting Q1 FY27 revenue of $33M, up 300% year-over-year and 75% quarter-over-quarter. Adjusted EPS was $0.28, beating estimates. The company raised FY27 revenue guidance to $150M, citing strong demand for AI and power semiconductor testing.

$AEHRHighAI 9/10

Aehr Stock Jumps 16% After Bookings Hit $46.7 Million

Aehr Test Systems (AEHR) shares rose 16.38% premarket after its Q1 revenue tripled to $33.0M, beating estimates. The company raised its full-year outlook to $150M, citing strong bookings and backlog growth. CEO Gayn Erickson highlighted a major AI customer opportunity. According to GuruFocus, there are 6 warning signs with AEHR.

$AEHRHighAI 8/10

Why is Aehr Test Systems stock surging today?

Aehr Test Systems (AEHR) stock surged 18.8% in pre-market trading after reporting record Q1 2027 revenue of $33.0M, up 200% YoY, and raising full-year revenue outlook to $150M. Non-GAAP net income was $9.4M, or $0.28 per share, exceeding analyst estimates. The company cited strong demand for AI semiconductor test solutions and a book-to-bill ratio of 1.4.

$AEHRMed

Aehr stock jumps on beat and raise amid AI demand

Aehr Test Systems (AEHR) shares rose 15% after reporting Q1 revenue of $33M, up 200% YoY, and raising its FY2027 outlook to $150M. The company cited strong demand for its semiconductor testing systems used in AI chips. CEO Gayn Erickson noted a conservative approach to the revised target. Bookings were $46.7M with a book-to-bill ratio of 1.4.